Provider of reagents and kits for molecular biology research. The product line includes gene expression vectors, protein expression detection and quantification, protein-protein and protein-ligand interactions, antibodies, reporter kits, and assays. Founded in 2003, headquartered in Beijing, China. The company has raised $21.2M in funding at the series b stage. The team comprises 8 (Jun 30, 2026) employees. Backed by investors including Shenzhen Guozhong Venture Capital Management, haierhealth.net, Huapont Life Sciences. The company is tagged with Tech, Enterprise. Pregene is recognized as a minicorn.
← All startups
Pregene
Series BProvider of reagents and kits for molecular biology research. The product line includes gene expression vectors, protein expression detection and quantification, protein-protein and protein-ligand interactions, antibodies, reporter kits, and assays. Founded in 2003, headquartered in Beijing, China. The company has raised $21.2M in funding at the series b stage. The team comprises 8 (Jun 30, 2026) employees. Backed…
About
Business model
Genomics > Enabling Technologies > Kits and Reagents > Suite,
Life Sciences Platforms and Tools > Research Reagents and Kits > Diversified
Institutional investors
Shenzhen Guozhong Venture Capital Managementhaierhealth.netHuapont Life Sciences
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ See who's investing in Life Sciences — full fund directory with check size and geography.